n-Butyrate Concentration Test · Stool

If you have ongoing gut symptoms, inflammatory bowel disease, or you have been loading up on fiber without feeling better, the answer may live in what your gut bacteria are actually producing. Butyrate is the main fuel your colon cells run on, and low output often shows up before visible damage or inflammation appears on other tests.

This test captures how much n-butyrate (also called butyric acid) is in your stool right now. That number reflects the combined output of the butyrate-making bacteria living in your gut, and it is one of the clearest windows into whether the fiber you eat is being converted into the compound your colon needs most.

What n-Butyrate Actually Does

Butyrate is a small fatty acid produced when friendly gut bacteria ferment the fiber and resistant starch you eat. The cells lining your colon (called colonocytes) use it to cover roughly 70 to 80 percent of their energy needs. Without a steady supply, these cells run on a lower fuel grade and the lining they maintain starts to weaken.

Beyond fuel, butyrate acts as a signaling molecule. It activates receptors on immune and gut cells and changes how certain genes get read, which helps calm inflammation, support regulatory immune cells, and keep the gut wall tightly sealed. When butyrate is low, the barrier becomes leakier and inflammation has an easier time taking hold.

Inflammatory Bowel Disease

People with ulcerative colitis and Crohn's disease consistently show reduced fecal butyrate and a loss of key butyrate-producing bacteria such as Faecalibacterium prausnitzii. This shortage leaves colon cells without their preferred fuel and the gut wall less able to resist inflammation. Studies of butyrate-focused therapies, including supplements and butyrogenic diets, suggest they can help reduce inflammation and support remission in some IBD (inflammatory bowel disease) cases, though these are not yet standalone treatments.

Colorectal Cancer Risk

A Bayesian meta-analysis of 14 studies found that higher butyrate was associated with roughly 37 percent lower odds of colorectal cancer (odds ratio 0.63, 95 percent credible interval 0.51 to 0.77). A separate systematic review of 23 observational studies reported that people with colorectal cancer or at high risk for it had meaningfully lower fecal butyrate than controls.

A small case-control study used a stool butyrate cutoff below 5.4 µg per milliliter (a very low concentration unit) to flag colorectal cancer, with 85 percent sensitivity and 78 percent specificity. The sample size was tiny (14 cases, 14 controls), so these numbers are suggestive rather than definitive. A large UK Biobank analysis that tracked 343,621 people for a median of 9.4 years found that higher whole-grain fiber intake was linked to lower colorectal cancer risk mainly in people genetically predicted to produce more butyrate, hinting that the protective effect of fiber may flow partly through this pathway.

Blood Pressure and Heart Health

In the SPIRIT trial, which followed 121 overweight or obese cancer survivors for 12 months, higher stool butyrate at baseline was tied to a lower chance of having high blood pressure (prevalence ratio 0.71, 95 percent confidence interval 0.54 to 0.92, meaning about 29 percent lower prevalence). Over the study, every 10 percent rise in fecal butyrate was associated with a drop of 0.56 mmHg in systolic blood pressure. This is a modest shift per unit, but it is one of the few long-term human studies linking measured butyrate to a hard clinical number.

Chronic Kidney Disease and Other Conditions

Human research also links reduced butyrate-producing bacteria to chronic kidney disease, ME/CFS (a severe fatigue condition also called myalgic encephalomyelitis or chronic fatigue syndrome), Parkinson's disease, rheumatoid arthritis, and gut injury after chemotherapy. In most of these studies the direct stool butyrate level has not been measured as carefully as in the IBD or colorectal cancer work, so the signal is suggestive rather than diagnostic.

Why One Reading Is Not Enough

Stool butyrate moves with your diet, your microbiome, and even the time of day you collect the sample. A single number tells you very little on its own. Tracking the same measurement over months, especially when you change your fiber intake, add a targeted fermentable food, or treat an underlying gut issue, tells you whether the biology is actually shifting.

A reasonable cadence is a baseline reading, a retest three to six months later if you are making diet or microbiome changes, and at least annual tracking once you have a trend established. Pair your test with a stool collection habit (same time of day, similar diet the day before) so your trend reflects your biology rather than what you ate last night.

What to Do with an Abnormal Result

A low stool butyrate reading on its own is not a diagnosis. The useful question is what it sits alongside. If your butyrate is low and you also have low fecal calprotectin, no blood in your stool, and no symptoms, you have an opportunity for a fiber and microbiome-focused intervention before anything clinical develops. If butyrate is low alongside elevated calprotectin, ongoing diarrhea, abdominal pain, or blood in stool, that pattern warrants workup for inflammatory bowel disease with a gastroenterologist.

Useful companion tests include calprotectin (a stool marker of gut inflammation), pancreatic elastase 1 (for digestive enzyme output), a broader short-chain fatty acid panel including acetate and propionate, and a stool microbiome analysis that identifies whether key butyrate producers like Faecalibacterium prausnitzii and Roseburia are present. The pattern across these markers is more informative than any single reading.

When Results Can Be Misleading

• Recent antibiotic use: antibiotics can wipe out butyrate-producing bacteria for weeks, artificially lowering your reading without reflecting your usual state.
• Collection timing: stool metabolites show day-to-day swings, and a same-day diet change or bowel habit shift can move the number.
• Sample handling: delays in freezing or unusual storage conditions can degrade the short-chain fatty acids in the sample before the lab ever sees them.
• Recent dietary change: a sudden increase in fiber or resistant starch in the days before testing can make levels look higher than your long-term baseline.